AMRX vs MSFT: Which Stock is Better?
Side-by-side comparison of Amneal Pharmaceuticals Inc and Microsoft Corp in 2026
AMRX
Amneal Pharmaceuticals Inc
$13.09
MSFT
Microsoft Corp
$430.11
Key Metrics Comparison
| Metric | AMRX | MSFT | Winner |
|---|---|---|---|
| Market Cap | $4.16B | N/A | AMRX |
| P/E Ratio | 59.32 | 26.32 | MSFT |
| EPS (TTM) | $0.22 | $15.97 | MSFT |
| Revenue Growth | 0.1% | 0.2% | MSFT |
| Gross Margin | 37.4% | 68.6% | MSFT |
Analyze AMRX
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is AMRX or MSFT a better investment?
Comparing AMRX and MSFT: Amneal Pharmaceuticals Inc has a market cap of $4.16B while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between AMRX and MSFT?
AMRX (Amneal Pharmaceuticals Inc) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: AMRX or MSFT?
Based on P/E ratios, MSFT trades at a lower multiple (26.3x vs 59.3x).
Which is growing faster: AMRX or MSFT?
MSFT has higher revenue growth at 0.2% vs 0.1% for AMRX.
Which company is more profitable: AMRX or MSFT?
Microsoft Corp (MSFT) has higher gross margins at 68.6% compared to 37.4% for AMRX.
Which is the larger company: AMRX or MSFT?
Amneal Pharmaceuticals Inc (AMRX) is larger with a market cap of $4.16B compared to N/A for MSFT.
Should I buy AMRX or MSFT in 2026?
Both AMRX and MSFT have investment merit. AMRX trades at $13.09 while MSFT trades at $430.11. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between AMRX and MSFT stock?
Key differences: Market Cap ($4.16B vs N/A), P/E Ratio (59.3x vs 26.3x), Revenue Growth (0.1% vs 0.2%), Gross Margin (37.4% vs 68.6%).